Equities

Rxsight Inc

RXST:NMQ

Rxsight Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)24.76
  • Today's Change-0.34 / -1.35%
  • Shares traded938.43k
  • 1 Year change-52.88%
  • Beta1.2572
Data delayed at least 15 minutes, as of Mar 10 2025 20:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments237127106
Total Receivables, Net302011
Total Inventory221715
Prepaid expenses4.543.522.96
Other current assets, total------
Total current assets294168135
Property, plant & equipment, net241314
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets0.360.150.77
Total assets319183150
LIABILITIES
Accounts payable4.543.862.60
Accrued expenses151211
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.030.040.15
Other current liabilities, total5.904.603.68
Total current liabilities262117
Total long term debt0.110.1240
Total debt0.130.1640
Deferred income tax------
Minority interest------
Other liabilities, total111.172.81
Total liabilities372260
SHAREHOLDERS EQUITY
Common stock0.040.040.03
Additional paid-in capital903755636
Retained earnings (accumulated deficit)(622)(595)(546)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.17(0.01)(0.1)
Total equity28116090
Total liabilities & shareholders' equity319183150
Total common shares outstanding403628
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.